Revenue

The sale of Care Bears to Authentic Brands Group is more than a business deal. It's a masterclass in how private equity is mining nostalgia for profit.

Shareholders overwhelmingly approve the $6.6B Brink's-NCR Atleos deal, creating a financial services behemoth poised to dominate the global cash and ATM landscape.

BEN's purchase of Cataneo signals a major shift. By embedding its AI into established ad infrastructure, the company aims for real-world results, not just hype.

Farmmi Inc. just raised $3 million, but the real story is the 80% discount and massive shareholder dilution. A look at the true cost of staying afloat.

Partnership Mastermind appoints Jen Kalant as CPO to fix a widespread 'execution problem.' As companies leave revenue on the table, her mission is to turn partner potential into profit.

Scott Kirby's 'Executive of the Year' award isn't just for surviving turbulence. It's for a high-risk, high-reward strategy that's reshaping United's future.

The tech firm's new funding addresses urgent debt amid Nasdaq delisting threats, revealing a complex financial maneuver to keep its K-culture dreams alive.

With its third CEO in a year, Rocky Mountain Chocolate Factory bets on a familiar face. But as shares plunge, the move raises questions about the path to recovery.

A seasoned transformation expert joins an AI innovator to finally deliver on enterprise software's broken promises. Can Somesh Khanna help ASAPP master the agentic era?

A landmark report challenges the doomsday narrative around Google's AI Overviews, revealing that brands measuring true impact, not just clicks, saw revenues climb.

RTX's F119 engine hit one million flight hours, securing the F-22's dominance. For investors, this milestone reveals a lucrative, decades-long sustainment model.

A quiet tech firm's expanding $45M deal with a top US carrier reveals the strategy behind securing millions of government mobile devices. Here's the inside story.

As Interactive Brokers preps its Q2 2026 earnings call, all eyes are on how its aggressive AI integration and market expansion will translate into growth.

By partnering with manufacturing giant Sanmina, Microbot Medical is telegraphing its shift from a promising MedTech firm to a serious global contender.

As Pure Cycle preps for its Investor Day, a closer look reveals a unique strategy where water rights fuel land development and create a recurring revenue engine.

A new survey reveals dermatologists are losing revenue and autonomy as operational pressures and AI-informed patients mount, pushing many toward private equity.

An Israeli networking specialist just landed a game-changing deal in AI infrastructure. It’s more than a win; it’s a look at the hidden systems building our AI future.

Saluda Medical secures FDA approval for its CAP24™ paddle lead, expanding its advanced closed-loop neuromodulation to surgeons and chronic pain patients.

Suominen's oversubscribed rights issue raises €28M, a strong investor endorsement for its ambitious 'Full Potential Program' aimed at a major overhaul.